Potential of faecal RNA in diagnosing colorectal cancer

Cancer Letters

Volumn 226, Issue 1, 2005, Pages 55-63

  Yang, Shung Haur ^a,b   Chien, Chih Cheng ^c,d   Chen, Chan Wei ^c   Li, Shih Yun ^a   Huang, Chi Jung ^c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Colorectal cancer; Cytokeratin 19; Differential expressed genes; Faecal total RNA

Indexed keywords

CYTOKERATIN 19; RNA;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FECES; FECES ANALYSIS; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC MARKER; HUMAN; MALE; METASTASIS; NON INVASIVE MEASUREMENT; NUCLEOTIDE SEQUENCE; PATIENT; PRIORITY JOURNAL; RNA PURIFICATION;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FECES; GENE EXPRESSION PROFILING; HUMANS; KERATINS; MASS SCREENING; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 21744448994     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.11.005     Document Type: Article

References (36)

1. D.A. Ahlquist, J.J. Harrington, L.J. Burgart, and P.C. Roche Morphometric analysis of the 'mucocellular layer' overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening Hum. Pathol. 31 2000 51 57
2. D.A. Ahlquist, and A.P. Shuber Stool screening for colorectal cancer: evolution from occult blood to molecular markers Clin. Chim. Acta. 315 2002 157 168
3. D.A. Ahlquist, J.E. Skoletsky, K.A. Boynton, J.J. Harrington, D.W. Mahoney, and W.E. Pierceall Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel Gastroenterology 119 2000 1219 1227
4. G.P. Albaugh, V. Iyengar, A. Lohani, M. Malayeri, S. Bala, and P.P. Nair Isolation of exfoliated colonic epithelial cells, a novel, non-invasive approach to the study of cellular markers Int. J. Cancer 52 1992 347 350
5. R.J. Alexander, and R.F. Raicht Purification of total RNA from human stool samples Dig. Dis. Sci. 43 1998 2652 2658
6. L. Baricault, B. de Nechaud, C. Sapin, P. Codogno, P. Denoulet, and G. Trugnan The network organization and the phosphorylation of cytokeratins are concomitantly modified by forskolin in the enterocyte-like differentiated Caco-2 cell line J. Cell Sci. 107 1994 2909 2918
7. N. Berois, M. Varangot, B. Aizen, R. Estrugo, L. Zarantonelli, and P. Fernandez Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR Eur. J. Cancer 36 2000 717 723
8. L.A. Davidson, C.M. Aymond, Y.H. Jiang, N.D. Turner, J.R. Lupton, and R.S. Chapkin Non-invasive detection of fecal protein kinase C betaII and zeta messenger RNA: putative biomarkers for colon cancer Carcinogenesis 19 1998 253 257
9. G. Davies, W.G. Jiang, and M.D. Mason Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion Clin. Cancer Res. 7 2001 3289 3297
10. S.M. Dong, G. Traverso, C. Johnson, L. Geng, R. Favis, and K. Boynton Detecting colorectal cancer in stool with the use of multiple genetic targets J. Natl. Cancer Inst. 93 2001 858 865
11. M. Galan, N. Vinolas, D. Colomer, G. Soler, M. Munoz, and R. Longaron Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation Anticancer Res. 22 2002 2877 2884
12. D.H. Grimm, Y. Cai, V. Chauvet, V. Rajendran, R. Zeltner, and L. Geng Polycystin-1 distribution is modulated by polycystin-2 expression in mammalian cells J. Biol. Chem. 278 2003 36786 36793
13. N. Hawkins, M. Norrie, K. Cheong, E. Mokany, S.L. Ku, and A. Meagher CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability Gastroenterology 122 2002 1376 1387
14. P. Hermanek pTNM and residual tumor classifications: problems of assessment and prognostic significance World J. Surg. 19 1995 184 190
15. M.S. Ismail, W. Wynendaele, J.L. Aerts, R. Paridaens, R. Gaafar, and N. Shakankiry Detection of micrometastatic disease and monitoring of perioperative tumor cell dissemination in primary operable breast cancer patients using real-time quantitative reverse transcription-PCR Clin. Cancer Res. 10 2004 196 201
16. V. Iyengar, G.P. Albaugh, A. Lohani, and P.P. Nair Human stools as a source of viable colonic epithelial cells Fed. Am. Soc. Exp. Biol. J. 5 1991 2856 2859
17. A. Jemal, R.C. Tiwari, T. Murray, A. Ghafoor, A. Samuels, and E. Ward Cancer statistics, 2004 CA Cancer J. Clin. 54 2004 8 29
18. M. Kawada, M. Mizuno, J. Nasu, T. Uesu, H. Okazaki, and H. Okada Release of decay-accelerating factor into stools of patients with colorectal cancer by means of cleavage at the site of glycosylphosphatidylinositol anchor J. Lab. Clin. Med. 142 2003 306 312
19. A. Loktionov, I.K. O'Neill, K.R. Silvester, J.H. Cummings, S.J. Middleton, and R. Miller Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer Clin. Cancer Res. 4 1998 337 342
20. T. Majima, T. Ichikura, E. Takayama, K. Chochi, and H. Mochizuki Detecting circulating cancer cells using reverse transcriptase-polymerase chain reaction for cytokeratin mRNA in peripheral blood from patients with gastric cancer Jpn. J. Clin. Oncol. 30 2000 499 503
21. J. Marchena, M.A. Acosta, F. Garcia-Anguiano, H. Simpson, and F. Cruz Use of the preoperative levels of CEA in patients with colorectal cancer Hepatogastroenterology 50 2003 1017 1020
22. M. Nakagawa, M. Mizuno, M. Kawada, T. Uesu, J. Nasu, and K. Takeuchi Polymorphic expression of decay-accelerating factor in human colorectal cancer J. Gastroenterol. Hepatol. 16 2001 184 189
23. C.S. Potten, and T.D. Allen Ultrastructure of cell loss in intestinal mucosa J. Ultrastruct. Res. 60 1977 272 277
24. H.F. Raskin, and S. Pleticka Exfoliative cytology of the colon Fifteen years of lost opportunity, Cancer 28 1971 127 130
25. C. Rengucci, P. Maiolo, L. Saragoni, W. Zoli, D. Amadori, and D. Calistri Multiple detection of genetic alterations in tumors and stool Clin. Cancer. Res. 7 2001 590 593
26. D. Sidransky, T. Tokino, S.R. Hamilton, K.W. Kinzler, B. Levin, and P. Frost Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors Science 256 1992 102 105
27. J.M. Silva, R. Rodriguez, J.M. Garcia, C. Munoz, J. Silva, and G. Dominguez Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells Gut 50 2002 530 534
28. J. Smith-Ravin, J. England, I.C. Talbot, and W. Bodmer Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients Gut 36 1995 81 86
29. A. Stathopoulou, D. Mavroudis, M. Perraki, S. Apostolaki, I. Vlachonikolis, and E. Lianidou Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers Anticancer Res. 23 2003 1883 1890
30. J. Strater, U. Wedding, T.F. Barth, K. Koretz, C. Elsing, and P. Moller Rapid onset of apoptosis in vitro follows disruption of beta 1-integrin/matrix interactions in human colonic crypt cells Gastroenterology 110 1996 1776 1784
31. E. Tokunaga, M. Ishida, Y. Kimura, and Y. Maehara Correlation with bone metastasis and high expression of CK 19 mRNA measured by quantitative RT-PCR in the bone marrow of breast cancer patients Breast J. 9 2003 440 442
32. T. Uenishi, S. Kubo, T. Yamamoto, T. Shuto, M. Ogawa, and H. Tanaka Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence Cancer Sci. 94 2003 851 857
33. C.A. Whittier, W. Horne, B. Slenning, M. Loomis, and M.K. Stoskopf Comparison of storage methods for reverse-transcriptase PCR amplification of rotavirus RNA from gorilla (Gorilla g. gorilla) fecal samples J. Virol. Methods 116 2004 11 17
34. I.H. Wong, W. Yeo, A.T. Chan, and P.J. Johnson Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression Cancer Lett. 162 2001 65 73
35. T. Yamao, Y. Matsumura, Y. Shimada, Y. Moriya, K. Sugihara, and T. Akasu Abnormal expression of CD44 variants in the exfoliated cells in the feces of patients with colorectal cancer Gastroenterology 114 1998 1196 1205
36. C.C. Yuan, P.H. Wang, H.T. Ng, Y.F. Li, T.S. Huang, and C.Y. Chen Detecting cytokeratin 19 mRNA in the peripheral blood cells of cervical cancer patients and its clinical-pathological correlation Gynecol. Oncol. 85 2002 148 153